Catch what you missed. Revisit what inspired you.
If you missed a session at ADLM 2026, check for the session recording through the available list on our website. Member all access registrants get complimentary access!
Since its launch in 2018, the ADLM Disruptive Technology Award has recognized breakthrough diagnostics from many innovative companies.
Finalists: Chemeleon and MagIC Lifescience
Semifinalists: BloodScan Biotech Inc, C2N Diagnostics, and Truvian
Finalists: Dionysus Digital Health and Vitestro
Semifinalists: Babson Diagnostics, Meliolabs, and PBD Biotech
Finalists: MS Pen Technologies, Inc. and Vital Biosciences Inc.
Semifinalists: Cardio Diagnostics Holdings, Inc, Eximius Diagnostics Corporation, and Micronoma
Finalists: Biological Dynamics, Inc. and Visby Medical
Semifinalists: Co-Diagnostics, Inc., Cytovale Inc., and FloBio LLC
Finalists: Mammoth Biosciences and MeMed
Semifinalists: numares GROUP Corporation, OncoHost, and Sight Diagnostics
Finalists: Alcediag and Sherlock Biosciences
Semifinalists: Cardea Bio, Geneoscopy, and Zepto Life Technology
Finalists: PixCell Medical and Singlera Genomics
Semifinalists: Bacteromic, COMBiNATi, Newomics, and PCR ONE
Finalists: Ativa Medical and Two Pore Guys
Semifinalists: Brevitest, Druley Lab, miDiagnostics, and PROMISE